Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc.

CLDX Clue Score15
United States Fiscal year ends December CIK 0000744218 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Samuel Bates Martin
2 Jan 2026
SVP and CFO
Exercised, kept
4,817
$10.38
$50.00K
Ronald Pepin
15 Dec 2025
Sr. VP & Cbo
Exercised, kept
11,000
$2.78
$30.58K
Ronald Pepin
15 Dec 2025
Sr. VP & Cbo
Exercised, kept
8,333
$9.02
$75.13K
Freddy A. Jimenez
4 Dec 2025
SVP & General Counsel
Sell
4,166
$29.10
$121.21K
Richard M. Wright
13 Nov 2025
Former Officer
Sold after exercise
49,298
$24.00
$1.18M

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 73,448
History held since 8 Jan 2007